Sarepta Therapeutics(SRPT) - 2025 Q4 - Earnings Call Transcript

Sarepta Therapeutics (NasdaqGS:SRPT) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsBrian Abrahams - Managing Director and Co-Head of Biotechnology Equity ResearchDoug Ingram - President and Chief Executive OfficerIan M. Estepan - VP of Investor RelationsLouise Rodino-Klapac - Executive VP, Chief Scientific Officer, and Head of Research and DevelopmentMichael Yee - Global Head of Biotechnology Equity ResearchPatrick Moss - Executive VP and Chief Commercial OfficerRyan Wong - Interim ...